Maricruz Rivera1, Sofya Norman2, Ryka Sehgal2, Rupa Juthani3. 1. Department of Neurological Surgery, Weill Cornell Medicine, New York, NY, USA. 2. Weill Cornell Medical College, New York, NY, USA. 3. Department of Neurological Surgery, Weill Cornell Medicine, New York, NY, USA. rgj9002@med.cornell.edu.
Abstract
PURPOSE OF REVIEW: This review summarizes the modern approach to surgical management of malignant brain tumors, highlighting new technology and multimodal treatment paradigms. RECENT FINDINGS: Outcomes in patients with glioblastoma are strongly correlated with extent of initial surgical resection. Intraoperative MRI, 5-ALA, and neuronavigation are surgical tools that can help achieve a maximal safe resection. Stereotactic radiosurgery and brachytherapy can be used to enhance local control for brain metastases in conjunction with surgery, while combinatorial approaches are increasingly employed in patients with multiple metastases. Advances in surgical techniques allow for minimally invasive approaches, including the use of tubular retractors, endoscopes, and laser interstitial thermal therapy. Primary and metastatic brain tumors require a multimodal, multidisciplinary approach to treatment. Surgical resection can be paired with radiation for metastases to maximize tumor control, expanding systemic options. Technological innovations have improved the safety of surgical resection, while expanding the surgical options and indications for treatment.
PURPOSE OF REVIEW: This review summarizes the modern approach to surgical management of malignant brain tumors, highlighting new technology and multimodal treatment paradigms. RECENT FINDINGS: Outcomes in patients with glioblastoma are strongly correlated with extent of initial surgical resection. Intraoperative MRI, 5-ALA, and neuronavigation are surgical tools that can help achieve a maximal safe resection. Stereotactic radiosurgery and brachytherapy can be used to enhance local control for brain metastases in conjunction with surgery, while combinatorial approaches are increasingly employed in patients with multiple metastases. Advances in surgical techniques allow for minimally invasive approaches, including the use of tubular retractors, endoscopes, and laser interstitial thermal therapy. Primary and metastatic brain tumors require a multimodal, multidisciplinary approach to treatment. Surgical resection can be paired with radiation for metastases to maximize tumor control, expanding systemic options. Technological innovations have improved the safety of surgical resection, while expanding the surgical options and indications for treatment.
Authors: Maryam Rahman; Joseph Abbatematteo; Edward K De Leo; Paul S Kubilis; Sasha Vaziri; Frank Bova; Elias Sayour; Duane Mitchell; Alfredo Quinones-Hinojosa Journal: J Neurosurg Date: 2016-09-30 Impact factor: 5.115
Authors: Maarten M J Wijnenga; Pim J French; Hendrikus J Dubbink; Winand N M Dinjens; Peggy N Atmodimedjo; Johan M Kros; Marion Smits; Renske Gahrmann; Geert-Jan Rutten; Jeroen B Verheul; Ruth Fleischeuer; Clemens M F Dirven; Arnaud J P E Vincent; Martin J van den Bent Journal: Neuro Oncol Date: 2018-01-10 Impact factor: 12.300
Authors: Todd C Hollon; Balaji Pandian; Arjun R Adapa; Esteban Urias; Akshay V Save; Siri Sahib S Khalsa; Daniel G Eichberg; Randy S D'Amico; Zia U Farooq; Spencer Lewis; Petros D Petridis; Tamara Marie; Ashish H Shah; Hugh J L Garton; Cormac O Maher; Jason A Heth; Erin L McKean; Stephen E Sullivan; Shawn L Hervey-Jumper; Parag G Patil; B Gregory Thompson; Oren Sagher; Guy M McKhann; Ricardo J Komotar; Michael E Ivan; Matija Snuderl; Marc L Otten; Timothy D Johnson; Michael B Sisti; Jeffrey N Bruce; Karin M Muraszko; Jay Trautman; Christian W Freudiger; Peter Canoll; Honglak Lee; Sandra Camelo-Piragua; Daniel A Orringer Journal: Nat Med Date: 2020-01-06 Impact factor: 53.440
Authors: Paolo Palmisciano; Ali S Haider; Kishore Balasubramanian; Randy S D'Amico; Alla Gabriella Wernicke Journal: J Neurooncol Date: 2022-06-13 Impact factor: 4.506
Authors: Jacopo Falco; Abramo Agosti; Ignazio G Vetrano; Alberto Bizzi; Francesco Restelli; Morgan Broggi; Marco Schiariti; Francesco DiMeco; Paolo Ferroli; Pasquale Ciarletta; Francesco Acerbi Journal: J Clin Med Date: 2021-05-17 Impact factor: 4.241